These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 17439507

  • 1. Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin.
    Casellas F, Borruel N, Torrejón A, Varela E, Antolin M, Guarner F, Malagelada JR.
    Aliment Pharmacol Ther; 2007 May 01; 25(9):1061-7. PubMed ID: 17439507
    [Abstract] [Full Text] [Related]

  • 2. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB, Sandborn WJ, Kornbluth A, Katz S, Safdi M, Woogen S, Regalli G, Yeh C, Smith-Hall N, Ajayi F.
    Am J Gastroenterol; 2005 Nov 01; 100(11):2478-85. PubMed ID: 16279903
    [Abstract] [Full Text] [Related]

  • 3. Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study.
    D'Haens G, Hommes D, Engels L, Baert F, van der Waaij L, Connor P, Ramage J, Dewit O, Palmen M, Stephenson D, Joseph R.
    Aliment Pharmacol Ther; 2006 Oct 01; 24(7):1087-97. PubMed ID: 16984503
    [Abstract] [Full Text] [Related]

  • 4. Additional oligofructose/inulin does not increase faecal bifidobacteria in critically ill patients receiving enteral nutrition: a randomised controlled trial.
    Majid HA, Cole J, Emery PW, Whelan K.
    Clin Nutr; 2014 Dec 01; 33(6):966-72. PubMed ID: 24290345
    [Abstract] [Full Text] [Related]

  • 5. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Forbes A, Bjarnason I, Sherwood RA, Ciclitira P, Nicholls JR.
    Eur J Gastroenterol Hepatol; 2008 Mar 01; 20(3):174-9. PubMed ID: 18301296
    [Abstract] [Full Text] [Related]

  • 6. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
    Lichtenstein GR, Kamm MA, Sandborn WJ, Lyne A, Joseph RE.
    Aliment Pharmacol Ther; 2008 Jun 01; 27(11):1094-102. PubMed ID: 18363894
    [Abstract] [Full Text] [Related]

  • 7. Metabolic and inflammatory faecal markers in collagenous colitis.
    Wildt S, Nordgaard-Lassen I, Bendtsen F, Rumessen JJ.
    Eur J Gastroenterol Hepatol; 2007 Jul 01; 19(7):567-74. PubMed ID: 17556903
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial.
    Miner PB, Wedel MK, Xia S, Baker BF.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1403-13. PubMed ID: 16669955
    [Abstract] [Full Text] [Related]

  • 9. Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes.
    Griffin IJ, Davila PM, Abrams SA.
    Br J Nutr; 2002 May 15; 87 Suppl 2():S187-91. PubMed ID: 12088517
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prebiotic fructans have greater impact on luminal microbiology and CD3+ T cells in healthy siblings than patients with Crohn's disease: A pilot study investigating the potential for primary prevention of inflammatory bowel disease.
    Hedin CR, McCarthy NE, Louis P, Farquharson FM, McCartney S, Stagg AJ, Lindsay JO, Whelan K.
    Clin Nutr; 2021 Aug 15; 40(8):5009-5019. PubMed ID: 34364241
    [Abstract] [Full Text] [Related]

  • 14. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Incà R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F.
    Dig Liver Dis; 2007 Apr 15; 39(4):329-37. PubMed ID: 17347061
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ, Pruitt R, Gordon GL, Lamet M, Shaw A, Huang S, Mareya S, Forbes WP.
    Am J Gastroenterol; 2009 Jun 15; 104(6):1452-9. PubMed ID: 19491859
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.
    Montalto M, Curigliano V, Santoro L, Lombardi M, Covino M, Cammarota G, Dalvai S, D'Onofrio F, Gasbarrini A, Gasbarrini G.
    Eur J Gastroenterol Hepatol; 2006 Sep 15; 18(9):965-7. PubMed ID: 16894309
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis.
    van Deventer SJ, Wedel MK, Baker BF, Xia S, Chuang E, Miner PB.
    Aliment Pharmacol Ther; 2006 May 15; 23(10):1415-25. PubMed ID: 16669956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.